Flerie
28.00 SEK
+1.82 %
Less than 1K followers
FLERIE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Flerie
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 218.25 | 173.25 | 174.00 | 84.50 | 25.60 | 46.95 | 37.45 |
| Shares | 2.0 | 2.4 | 5.3 | 5.3 | 5.3 | 78.1 | 77.5 |
| Market cap | 429.3 | 410.2 | 926.9 | 450.1 | 136.4 | 3,665.2 | 2,900.7 |
| Enterprise value | 303.0 | 358.7 | 499.7 | 108.4 | - | 2,800.9 | - |
| EV/S | 3,442.8 | 10,247.9 | - | - | - | 28,009.2 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | - | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | - | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 4.03 | 8.32 | 2.14 | 1.35 | 0.57 | 0.87 | 0.86 |
| P/S | 4,878.1 | 11,719.1 | - | - | 1.4 | 36,652.2 | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 82.5 % | 80.6 % | 97.5 % | 95.1 % | 79.8 % | 99.4 % | 99.4 % |
| Gearing ratio | 0.5 % | 4.7 % | 0.3 % | 1.0 % | 1.0 % | 0.0 % | 0.1 % |